Matthias Eiber

12.7k total citations · 3 hit papers
200 papers, 6.2k citations indexed

About

Matthias Eiber is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Matthias Eiber has authored 200 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Radiology, Nuclear Medicine and Imaging, 155 papers in Pulmonary and Respiratory Medicine and 35 papers in Oncology. Recurrent topics in Matthias Eiber's work include Prostate Cancer Treatment and Research (143 papers), Radiopharmaceutical Chemistry and Applications (128 papers) and Medical Imaging Techniques and Applications (50 papers). Matthias Eiber is often cited by papers focused on Prostate Cancer Treatment and Research (143 papers), Radiopharmaceutical Chemistry and Applications (128 papers) and Medical Imaging Techniques and Applications (50 papers). Matthias Eiber collaborates with scholars based in Germany, United States and Switzerland. Matthias Eiber's co-authors include Wolfgang Weber, Wolfgang P. Fendler, Ken Herrmann, Jérémie Calais, Ernst J. Rummeny, Isabel Rauscher, Ambros J. Beer, Andrei Gafita, Tobias Maurer and Markus Schwaiger and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Matthias Eiber

191 papers receiving 6.2k citations

Hit Papers

First Clinical Experience with Integrated Whole-Body PET/... 2012 2026 2016 2021 2012 2017 2023 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses
    2012 391 citations Matthias Eiber, Sibylle Ziegler et al. Journal of Nuclear Medicine profile →
  2. Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT
    2017 386 citations Matthias Eiber, Ken Herrmann et al. Journal of Nuclear Medicine profile →
  3. Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)
    2023 127 citations Robert Seifert, Steven P. Rowe et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Eiber Germany 42 4.5k 4.1k 1.1k 626 405 200 6.2k
Jérémie Calais United States 37 2.7k 0.6× 3.5k 0.9× 1.3k 1.2× 857 1.4× 346 0.9× 218 4.9k
Andrei Iagaru United States 41 2.9k 0.6× 2.1k 0.5× 1.3k 1.2× 402 0.6× 246 0.6× 253 5.0k
Paolo Castellucci Italy 45 3.0k 0.7× 3.6k 0.9× 1.3k 1.1× 599 1.0× 412 1.0× 194 6.0k
Michael Souvatzoglou Germany 39 4.3k 1.0× 3.4k 0.8× 649 0.6× 774 1.2× 492 1.2× 100 6.2k
Kambiz Rahbar Germany 33 3.8k 0.8× 4.1k 1.0× 1.6k 1.4× 561 0.9× 169 0.4× 158 5.4k
Maria Picchio Italy 46 4.0k 0.9× 4.4k 1.1× 890 0.8× 991 1.6× 615 1.5× 202 7.5k
Isabel Rauscher Germany 33 2.8k 0.6× 3.7k 0.9× 608 0.5× 425 0.7× 692 1.7× 97 4.5k
Ali Afshar‐Oromieh Germany 45 6.9k 1.5× 6.9k 1.7× 2.0k 1.7× 747 1.2× 606 1.5× 149 9.2k
Wolfgang P. Fendler Germany 47 5.1k 1.1× 5.7k 1.4× 2.2k 1.9× 1.1k 1.8× 598 1.5× 294 8.3k
Hossein Jadvar United States 38 2.4k 0.5× 2.2k 0.5× 885 0.8× 526 0.8× 216 0.5× 184 4.5k

Countries citing papers authored by Matthias Eiber

Since Specialization
Citations

This map shows the geographic impact of Matthias Eiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Eiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Eiber more than expected).

Fields of papers citing papers by Matthias Eiber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Eiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Eiber. The network helps show where Matthias Eiber may publish in the future.

Co-authorship network of co-authors of Matthias Eiber

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Eiber. A scholar is included among the top collaborators of Matthias Eiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Eiber. Matthias Eiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woo, Sungmin, Samuel J. Withey, Roberto García‐Figueiras, et al.. (2025). ESUR: Opportunities for PSMA-PET/CT and whole-body MRI in advanced prostate cancer. European Radiology.
2.
Woo, Sungmin, Steven P. Rowe, Damiano Caruso, et al.. (2025). Navigating the Scoring Systems and Interpretation Frameworks of Prostate-specific Membrane Antigen PET. Radiology. 317(3). e250701–e250701.
3.
Vogel, Marco M. E., Isabel Rauscher, Jürgen E. Gschwend, et al.. (2025). Biochemical failure-free survival of 18F-rhPSMA-7 and 18F-flotufolastat PET-guided salvage radiotherapy for patients with recurrent prostate cancer. Scientific Reports. 15(1). 2234–2234. 1 indexed citations
4.
Vargas, Hebert Alberto, Stefano Fanti, Ken Herrmann, et al.. (2025). PSMA PET/CT Reporting: Real-Life Inconsistencies, Heterogeneity, and Underutilization of Scoring Systems and Interpretation Frameworks. Radiology. 317(1). e250702–e250702. 1 indexed citations
5.
Jungmann, Friederike, Georgios Kaissis, Robert Tauber, et al.. (2025). Automated CT Measurement of Total Kidney Volume for Predicting Renal Function Decline after 177Lu Prostate-specific Membrane Antigen–I&T Radioligand Therapy. Radiology. 314(2). e240427–e240427. 1 indexed citations
6.
7.
Seifert, Robert, Constantin Lapa, Wolfgang Weber, et al.. (2024). Safety and Efficacy of Extended Therapy with [177Lu]Lu-PSMA: A German Multicenter Study. Journal of Nuclear Medicine. 65(6). 909–916. 16 indexed citations
8.
Xue, Song, Andrei Gafita, Thomas Wendler, et al.. (2024). PBPK-Adapted Deep Learning for Pretherapy Prediction of Voxelwise Dosimetry: In-Silico Proof of Concept. IEEE Transactions on Radiation and Plasma Medical Sciences. 8(6). 646–654. 5 indexed citations
9.
Fendler, Wolfgang P., Matthias Eiber, Boris Hadaschik, et al.. (2024). Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial). Journal of Nuclear Medicine. 65(7). 1076–1079. 5 indexed citations
10.
Poulsen, Mads Hvid, Steinbjørn Hansen, Søren Hess, et al.. (2023). A randomised trial of [18F]PSMA‐1007‐PET/CT versus NaF‐PET/CT for staging primary prostate cancer: A trial protocol. SHILAP Revista de lepidopterología. 4(5). 513–522. 2 indexed citations
11.
Han, Yang, Kathrin A. Schmohl, Christian Zach, et al.. (2022). Mesenchymal Stem Cell–mediated Image-guided Sodium Iodide Symporter ( NIS ) Gene Therapy Improves Survival of Glioblastoma-bearing Mice. Clinical Cancer Research. 29(5). 930–942. 11 indexed citations
12.
Morath, Volker, Michael Heider, Jérémie Calais, et al.. (2022). Initial evaluation of [18F]-FACBC for PET imaging of multiple myeloma. EJNMMI Research. 12(1). 4–4. 4 indexed citations
13.
Gafita, Andrei, Thomas Wendler, Ali Afshar‐Oromieh, et al.. (2022). PBPK-Adapted Deep Learning for Voxel-Wise Organ Dosimetry Prediction. World Journal of Nuclear Medicine. 21(1). 85–98. 1 indexed citations
14.
Farolfi, Andrea, Paola Caroli, Juliano J. Cerci, et al.. (2022). PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study. Cancers. 14(22). 5680–5680. 6 indexed citations
15.
Ferdinandus, Justin, Wolfgang P. Fendler, Andrea Farolfi, et al.. (2021). PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study. Journal of Nuclear Medicine. 63(1). 76–80. 24 indexed citations
16.
Morath, Volker, Katja Steiger, Calogero D’Alessandria, et al.. (2021). Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?—An In Silico Study on the Role of Chronic Hypoxia in Prostate Cancer. Cancers. 13(14). 3429–3429. 15 indexed citations
17.
Kroenke, Markus, Thomas Horn, Jan C. Peeken, et al.. (2020). Matched-Pair Comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non–Tumor-Related Uptake and Tumor Positivity. Journal of Nuclear Medicine. 62(8). 1082–1088. 45 indexed citations
18.
Fendler, Wolfgang P., Manuel Weber, Amir Iravani, et al.. (2019). Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 25(24). 7448–7454. 183 indexed citations
19.
Pfob, Christian H., Moritz Jesinghaus, Alexander Novotny, et al.. (2018). Pitfalls in Ga-68-PSMA-PET/CT: incidental finding of parathyroid adenoma. European Journal of Nuclear Medicine and Molecular Imaging. 46(4). 1041–1041. 10 indexed citations
20.
Calais, Jérémie, Wolfgang P. Fendler, Matthias Eiber, et al.. (2017). Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence. Journal of Nuclear Medicine. 59(3). 434–441. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jérémie Calais Breakdown of academic impact, for papers by Andrei Iagaru Breakdown of academic impact, for papers by Paolo Castellucci Breakdown of academic impact, for papers by Michael Souvatzoglou Breakdown of academic impact, for papers by Kambiz Rahbar Breakdown of academic impact, for papers by Maria Picchio Breakdown of academic impact, for papers by Isabel Rauscher Breakdown of academic impact, for papers by Ali Afshar‐Oromieh Breakdown of academic impact, for papers by Wolfgang P. Fendler Breakdown of academic impact, for papers by Hossein Jadvar
Rankless by CCL
2026